nivlac
2021-07-09
Pls like
BioNTech shares rises 3.6% in premarket<blockquote>BioNTech股价盘前上涨3.6%</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
5
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":141990312,"tweetId":"141990312","gmtCreate":1625830438336,"gmtModify":1633936922831,"author":{"id":3576410555567456,"idStr":"3576410555567456","authorId":3576410555567456,"authorIdStr":"3576410555567456","name":"nivlac","avatar":"https://static.tigerbbs.com/20f49098bcdb5db4fdcfb746b729245d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Pls like </p></body></html>","htmlText":"<html><head></head><body><p>Pls like </p></body></html>","text":"Pls like","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/141990312","repostId":1180424186,"repostType":4,"repost":{"id":"1180424186","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625819933,"share":"https://www.laohu8.com/m/news/1180424186?lang=zh_CN&edition=full","pubTime":"2021-07-09 16:38","market":"us","language":"en","title":"BioNTech shares rises 3.6% in premarket<blockquote>BioNTech股价盘前上涨3.6%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180424186","media":"Tiger Newspress","summary":"BioNTech shares rises 3.6% in premarket trading,which is developing a booster shot specifically targ","content":"<p>BioNTech shares rises 3.6% in premarket trading,which is developing a booster shot specifically targeting the so-called delta variant of the virus that causes the disease.</p><p><blockquote>BioNTech股价在盘前交易中上涨3.6%，该公司正在开发一种专门针对导致该疾病的病毒的所谓德尔塔变异毒株的加强注射。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f41726c12e31bc4f3b7aaaf7cfbf1ac5\" tg-width=\"1281\" tg-height=\"605\">Pfizer Inc. and COVID-19 vaccine partner BioNTech said late Thursday they are developing a booster shot specifically targeting the so-called delta variant of the virus that causes the disease.</p><p><blockquote>辉瑞公司和COVID-19疫苗合作伙伴BioNTech周四晚间表示，他们正在开发一种加强疫苗，专门针对导致该疾病的病毒的所谓德尔塔变异毒株。</blockquote></p><p> The Wall Street Journal reported saying fully vaccinated Americans \"do not need a booster shot at this time,\" but that they are prepared for booster doses \"if and when the science demonstrates they are needed.\"</p><p><blockquote>《华尔街日报》报道称，完全接种疫苗的美国人“目前不需要加强注射”，但“如果科学证明需要”，他们已经准备好接受加强剂量。</blockquote></p><p> Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> said in a statement that there is encouraging data from the use of a third booster shot of their current BNT162b2 vaccine, which is widely administered in two doses given three weeks apart.</p><p><blockquote>辉瑞<a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>和BioNTech<a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>在一份声明中表示，使用当前BNT162b2疫苗的第三次加强注射的数据令人鼓舞，该疫苗广泛分两剂注射，间隔三周。</blockquote></p><p> \"While we believe a third dose of BNT162b2 has the potential to preserve the highest levels protective efficacy against all currently known variants including delta, we are remaining vigilant and are developing an updated version of the Pfizer-COVID-19 vaccine that uses a new construct based on the B.1.617.2 lineage, first identified in India and also known as the delta variant,\" the companies said in a statement.</p><p><blockquote>两家公司在一份声明中表示：“虽然我们相信第三剂BNT162b2有可能保持针对包括delta在内的所有目前已知变种的最高水平的保护效力，但我们仍保持警惕，并正在开发辉瑞COVID-19疫苗的更新版本，该疫苗使用新的B.1.617.2谱系的构建，首次在印度发现，也称为德尔塔变异毒株。”</blockquote></p><p> The companies also pointed to evidence from the Israeli Ministry of Health showing the effectiveness of the vaccine declined six months after the shots, just as the delta variant is taking hold in the country.</p><p><blockquote>这些公司还指出，以色列卫生部的证据显示，疫苗的有效性在注射六个月后下降，就在德尔塔变异毒株在该国蔓延之际。</blockquote></p><p> Pfizer and BioNTech expect to begin clinical trials to study a third dose in August.</p><p><blockquote>辉瑞和BioNTech预计将于8月开始研究第三剂疫苗的临床试验。</blockquote></p><p> \"That is why we have said, and we continue to believe, that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination,\" the companies said.</p><p><blockquote>“这就是为什么我们说过，并且我们仍然相信，根据我们迄今为止掌握的全部数据，很可能在全面接种疫苗后的6至12个月内需要第三剂疫苗，”这些公司说。</blockquote></p><p> On Thursday, Japan barred spectators from the Tokyo Olympics because of an uptick in COVID cases likely caused by the delta variant. Previously, only foreign spectators had been banned from attending the games in person.</p><p><blockquote>周四，日本禁止观众观看东京奥运会，因为德尔塔变异毒株可能导致COVID病例增加。此前，只有外国观众被禁止亲自观看比赛。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech shares rises 3.6% in premarket<blockquote>BioNTech股价盘前上涨3.6%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech shares rises 3.6% in premarket<blockquote>BioNTech股价盘前上涨3.6%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-09 16:38</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioNTech shares rises 3.6% in premarket trading,which is developing a booster shot specifically targeting the so-called delta variant of the virus that causes the disease.</p><p><blockquote>BioNTech股价在盘前交易中上涨3.6%，该公司正在开发一种专门针对导致该疾病的病毒的所谓德尔塔变异毒株的加强注射。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f41726c12e31bc4f3b7aaaf7cfbf1ac5\" tg-width=\"1281\" tg-height=\"605\">Pfizer Inc. and COVID-19 vaccine partner BioNTech said late Thursday they are developing a booster shot specifically targeting the so-called delta variant of the virus that causes the disease.</p><p><blockquote>辉瑞公司和COVID-19疫苗合作伙伴BioNTech周四晚间表示，他们正在开发一种加强疫苗，专门针对导致该疾病的病毒的所谓德尔塔变异毒株。</blockquote></p><p> The Wall Street Journal reported saying fully vaccinated Americans \"do not need a booster shot at this time,\" but that they are prepared for booster doses \"if and when the science demonstrates they are needed.\"</p><p><blockquote>《华尔街日报》报道称，完全接种疫苗的美国人“目前不需要加强注射”，但“如果科学证明需要”，他们已经准备好接受加强剂量。</blockquote></p><p> Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> said in a statement that there is encouraging data from the use of a third booster shot of their current BNT162b2 vaccine, which is widely administered in two doses given three weeks apart.</p><p><blockquote>辉瑞<a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a>和BioNTech<a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a>在一份声明中表示，使用当前BNT162b2疫苗的第三次加强注射的数据令人鼓舞，该疫苗广泛分两剂注射，间隔三周。</blockquote></p><p> \"While we believe a third dose of BNT162b2 has the potential to preserve the highest levels protective efficacy against all currently known variants including delta, we are remaining vigilant and are developing an updated version of the Pfizer-COVID-19 vaccine that uses a new construct based on the B.1.617.2 lineage, first identified in India and also known as the delta variant,\" the companies said in a statement.</p><p><blockquote>两家公司在一份声明中表示：“虽然我们相信第三剂BNT162b2有可能保持针对包括delta在内的所有目前已知变种的最高水平的保护效力，但我们仍保持警惕，并正在开发辉瑞COVID-19疫苗的更新版本，该疫苗使用新的B.1.617.2谱系的构建，首次在印度发现，也称为德尔塔变异毒株。”</blockquote></p><p> The companies also pointed to evidence from the Israeli Ministry of Health showing the effectiveness of the vaccine declined six months after the shots, just as the delta variant is taking hold in the country.</p><p><blockquote>这些公司还指出，以色列卫生部的证据显示，疫苗的有效性在注射六个月后下降，就在德尔塔变异毒株在该国蔓延之际。</blockquote></p><p> Pfizer and BioNTech expect to begin clinical trials to study a third dose in August.</p><p><blockquote>辉瑞和BioNTech预计将于8月开始研究第三剂疫苗的临床试验。</blockquote></p><p> \"That is why we have said, and we continue to believe, that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination,\" the companies said.</p><p><blockquote>“这就是为什么我们说过，并且我们仍然相信，根据我们迄今为止掌握的全部数据，很可能在全面接种疫苗后的6至12个月内需要第三剂疫苗，”这些公司说。</blockquote></p><p> On Thursday, Japan barred spectators from the Tokyo Olympics because of an uptick in COVID cases likely caused by the delta variant. Previously, only foreign spectators had been banned from attending the games in person.</p><p><blockquote>周四，日本禁止观众观看东京奥运会，因为德尔塔变异毒株可能导致COVID病例增加。此前，只有外国观众被禁止亲自观看比赛。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180424186","content_text":"BioNTech shares rises 3.6% in premarket trading,which is developing a booster shot specifically targeting the so-called delta variant of the virus that causes the disease.\nPfizer Inc. and COVID-19 vaccine partner BioNTech said late Thursday they are developing a booster shot specifically targeting the so-called delta variant of the virus that causes the disease.\nThe Wall Street Journal reported saying fully vaccinated Americans \"do not need a booster shot at this time,\" but that they are prepared for booster doses \"if and when the science demonstrates they are needed.\"\nPfizer $(PFE)$ and BioNTech $(BNTX)$ said in a statement that there is encouraging data from the use of a third booster shot of their current BNT162b2 vaccine, which is widely administered in two doses given three weeks apart.\n\"While we believe a third dose of BNT162b2 has the potential to preserve the highest levels protective efficacy against all currently known variants including delta, we are remaining vigilant and are developing an updated version of the Pfizer-COVID-19 vaccine that uses a new construct based on the B.1.617.2 lineage, first identified in India and also known as the delta variant,\" the companies said in a statement.\nThe companies also pointed to evidence from the Israeli Ministry of Health showing the effectiveness of the vaccine declined six months after the shots, just as the delta variant is taking hold in the country.\nPfizer and BioNTech expect to begin clinical trials to study a third dose in August.\n\"That is why we have said, and we continue to believe, that it is likely, based on the totality of the data we have to date, that a third dose may be needed within 6 to 12 months after full vaccination,\" the companies said.\nOn Thursday, Japan barred spectators from the Tokyo Olympics because of an uptick in COVID cases likely caused by the delta variant. Previously, only foreign spectators had been banned from attending the games in person.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":310,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/141990312"}
精彩评论